Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

SUV and ADC in lung: Do we really need both?

Sofia Michopoulou, Jokha Alkalbani, Rizwan Syed, Rakesh Sajjan, Anna Barnes, James Connelly, Zia Saad, Khalsa Al-Nabhani, Celia Omeara and Jamshed Bomanji
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 448;
Sofia Michopoulou
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jokha Alkalbani
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rizwan Syed
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakesh Sajjan
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Barnes
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Connelly
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zia Saad
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khalsa Al-Nabhani
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celia Omeara
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamshed Bomanji
1Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

448

Objectives To investigate the relationship between the Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) of lung tumours derived from simultaneous PET/MRI. We hypothesize that combining SUV results with ADC values derived from Diffusion Weighted Imaging can help differentiate between vital, fibrotic and necrotic tumours.

Methods To test this hypothesis we analysed simultaneous wholebody FDG PET/MRI scans from 18 patients with 22 lung lesions acquired on a Siemens Biograph mMR scanner. Free breathing axial 3-directional EPI diffusion data were acquired at 3 b-values (0, 400, 800s/mm2) to produce ADC maps. Lesions as small as 0.6 cm2 were detected. Irregular ROIs were drawn on T2 images and copied onto the attenuation corrected PET images and ADC maps to determine the maximum SUV and mean ADC values. Care was exercised to avoid areas of infection and artefacts across the air-tissue interface. The association between SUVmax and ADCmean was assessed using Spearman's rho correlation coefficient since the scatter plot indicated a non-linear relationship.

Results A strong negative correlation between ADCmean and SUVmax was identified (rho=-0.89, p<0.001) indicating that the more cellular the tissue (restricted diffusion, low ADC) the higher its metabolic rate (high SUV). However, the Diffusion - Metabolism relationship appears to be non-linear. Specifically, we observed that dense cellular tumours with ADC values lower than 1×10-3mm2/s demonstrate a wide range of metabolic uptakes (4<SUVmax<10). On the other hand, the diffusion patterns for tumours with lower FDG avidity (1<SUVmax<4) ranged from restricted motion indicating dense and even fibrous tissue all the way up to unrestricted water motion which can be representing necrotic tissue (1×10-3mm2/s<ADCmean<3×10-3mm2/s). This is showcased here by two examples of heterogeneous tumours with necrotic and fibrotic centres.

Conclusions These preliminary results yielded a strong association between ADCmean and SUVmax. Our findings indicate that combining SUV and ADC results can help distinguish necrotic tissue from fibrotic tissue and from vital tissue in lung tumours. To further validate these findings a larger prospective study is required, and we are currently recruiting patients with lung and colorectal tumours post-radiotherapy treatment.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SUV and ADC in lung: Do we really need both?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
SUV and ADC in lung: Do we really need both?
Sofia Michopoulou, Jokha Alkalbani, Rizwan Syed, Rakesh Sajjan, Anna Barnes, James Connelly, Zia Saad, Khalsa Al-Nabhani, Celia Omeara, Jamshed Bomanji
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 448;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
SUV and ADC in lung: Do we really need both?
Sofia Michopoulou, Jokha Alkalbani, Rizwan Syed, Rakesh Sajjan, Anna Barnes, James Connelly, Zia Saad, Khalsa Al-Nabhani, Celia Omeara, Jamshed Bomanji
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 448;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Quantitative analysis of blood-borne 18F-FMISO metabolites in cancer patients by HPLC using an integrated high-sensitivity coincidence detector
  • Longitudinal Analysis of Bone Metabolism Using SPECT/CT and Tc-99m-Diphosphono-Propanedicarboxylic Acid: Comparison of Visual and Quantitative Analysis
  • 188Re-microspheres for selective intra-arterial radionuclide therapy (SIRT) in patients with HCC: Feasibility study
Show more Oncology: Basic, Translational & Therapy

Biomarkers

  • Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ETS: Validation by direct comparison to 15O-water
  • Molecular simulation of receptor occupancy and tumor penetration of an antibody and smaller scaffolds: Application to molecular imaging
  • Low dose CT texture analysis (CTTA) can potentially sub-classify risk in lymphoma patients showing complete metabolic response on interim PET
Show more Biomarkers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire